Literature DB >> 11045983

Preserved ventricular contractility in infarcted mouse heart overexpressing beta(2)-adrenergic receptors.

X J Du1, X M Gao, G L Jennings, A M Dart, E A Woodcock.   

Abstract

Effects of cardiac specific overexpression of beta(2)-adrenergic receptors (beta(2)-AR) on the development of heart failure (HF) were studied in wild-type (WT) and transgenic (TG) mice following myocardial infarction (MI) by coronary artery occlusion. Animals were studied by echocardiography at weeks 7 to 8 and by catheterization at week 9 after surgery. Post-infarct mortality, due to HF or cardiac rupture, was not different among WT mice, and there was no difference in infarct size (IS). Compared with the sham-operated group (all P < 0.01), WT mice with moderate (<36%) and large (>36%) IS developed lung congestion, cardiac hypertrophy, left ventricular (LV) dilatation, elevated LV end-diastolic pressure (LVEDP), and suppressed maximal rate of increase of LV pressure (LV dP/dt(max)) and fractional shortening (FS). Whereas changes in organ weights and echo parameters were similar to those in infarcted WT groups, TG mice had significantly higher levels of LV contractility in both moderate (dP/dt(max) 4,862 +/- 133 vs. 3,694 +/- 191 mmHg/s) and large IS groups (dP/dt(max) 4,556 +/- 252 vs. 3,145 +/- 312 mmHg/s, both P < 0.01). Incidence of pleural effusion (36% vs. 85%, P < 0.05) and LVEDP levels (6 +/- 0.3 vs. 9 +/- 0.8 mmHg, P < 0.05) were also lower in TG than in WT mice with large IS. Thus beta(2)-AR overexpression preserved LV contractility following MI without adverse consequence.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045983     DOI: 10.1152/ajpheart.2000.279.5.H2456

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  7 in total

Review 1.  Gene therapy in heart failure.

Authors:  Leif Erik Vinge; Philip W Raake; Walter J Koch
Journal:  Circ Res       Date:  2008-06-20       Impact factor: 17.367

Review 2.  Genetically changed mice with chronic deficiency or overexpression of the beta-adrenoceptors--what can we learn for the therapy of heart failure?

Authors:  Samuel Lee; Robert H G Schwinger; Klara Brixius
Journal:  Pflugers Arch       Date:  2007-09-14       Impact factor: 3.657

Review 3.  Beta-adrenergic stimulation and myocardial function in the failing heart.

Authors:  Ali El-Armouche; Thomas Eschenhagen
Journal:  Heart Fail Rev       Date:  2009-12       Impact factor: 4.214

4.  β-Adrenergic Receptor-Stimulated Cardiac Myocyte Apoptosis: Role of β1 Integrins.

Authors:  Parthiv Amin; Mahipal Singh; Krishna Singh
Journal:  J Signal Transduct       Date:  2011-05-24

5.  Adaptations to iron deficiency: cardiac functional responsiveness to norepinephrine, arterial remodeling, and the effect of beta-blockade on cardiac hypertrophy.

Authors:  Lexa Rae Turner; Daniel Aaron Premo; Brett Jason Gibbs; Megan Lesley Hearthway; Madelyne Motsko; Andrea Sappington; LeeAnn Walker; Michael Eugene Mullendore; Herbert George Chew
Journal:  BMC Physiol       Date:  2002-01-09

6.  G protein, phosphorylated-GATA4 and VEGF expression in the hearts of transgenic mice overexpressing β1- and β2-adrenergic receptors.

Authors:  Hyun-Jin Tae; Natalia Petrashevskaya; In Hye Kim; Joon Ha Park; Jae-Chul Lee; Moo-Ho Won; Yang Hee Kim; Ji Hyeon Ahn; Jinseu Park; Soo Young Choi; Yong Hwan Jeon
Journal:  Mol Med Rep       Date:  2017-04-28       Impact factor: 2.952

7.  Cardiac physiologic regulation of sub-type specific adrenergic receptors in transgenic mice overexpressing β1- and β2-adrenergic receptors.

Authors:  Ka Eul Kim; Hyun-Jin Tae; Petrashevskaya Natalia; Jae-Chul Lee; Ji Hyeon Ahn; Joon Ha Park; In Hye Kim; Taek Geun Ohk; Chan Woo Park; Jun Hwi Cho; Moo-Ho Won
Journal:  Clin Exp Emerg Med       Date:  2016-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.